40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details

臨床試験数 : 25 / 薬物数 : 50 - (DrugBank : 21) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 114

10 trials found

diseases per page:

Showing 1 to 10 of 10 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04564001 (ClinicalTrials.gov)	September 2020	21/9/2020	Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocil ...	Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocil ...	Takayasu Arteritis	Drug: Infliximab;Drug: Tocilizumab	Assistance Publique - Hôpitaux de Paris	NULL	Not yet recruiting	18 Years	N/A	All	50	Phase 2	NULL
2	NCT04300686 (ClinicalTrials.gov)	March 1, 2020	5/3/2020	A Pilot Study in Severe Patients With Takayasu Arteritis.	A Pilot Study in the Treatment of Severe Patients With Takayasu Arteritis With Tocilizumaband Adalim ...	Takayasu Arteritis;Tocilizumab;Adalimumab;Treatment	Biological: Tocilizumab;Biological: Adalimumab	Shanghai Zhongshan Hospital	NULL	Recruiting	14 Years	100 Years	All	40	Phase 4	China
3	EUCTR2018-003753-13-FR (EUCTR)	19/03/2019	13/12/2018	INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritis	Multicentre, randomized, prospective trial comparing the efficacy and safety of Infliximab to tocili ...	Patients with refractory or relapsing Takayasu Arteritis desease;Therapeutic area: Analytical, Diagn ...	Trade Name: RoActemra 20mg/ml Product Name: Tocilizumab INN or Proposed INN: Tocilizumab Other descripti ...	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 3	France
4	JPRN-UMIN000025940	2017/02/07	07/02/2017	Clinical Research on the Safety of anti-interleukin-6 antibody (Tocilizumab) treatment for the refra ...	Clinical Research on the Safety of anti-interleukin-6 antibody (Tocilizumab) treatment for the refra ...	Takayasu arteritis	Intravenous administration of tocilizumab (8mg/kg/month) for up to 12 months	Osaka University	National Cerebral and Cardiovascular Center	Complete: follow-up continuing	16years-old	60years-old	Male and Female	2	Not selected	Japan
5	NCT03893136 (ClinicalTrials.gov)	November 1, 2016	12/3/2019	The Registry Study of Takayasu Arteritis in East China	The Cohort Study of East Chinese Takayasu's Arteritis (ECTA-cohort Study)	Takayasu Arteritis;Mechanisms, Defense;Pregnancy Related;Treatment Refusal;Outcome	Biological: Tocilizumab;Drug: Leflunomide	Shanghai Zhongshan Hospital	NULL	Recruiting	18 Years	65 Years	All	1000		China
6	JPRN-JapicCTI-142616	02/10/2014	23/07/2014	Phase III Study of MRA-SC in Patients with Takayasu Arteritis	A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study of MRA-SC in Patients ...	Takayasu Arteritis	Intervention name : tocilizumab (MRA-SC) INN of the intervention : tocilizumab Dosage And administratio ...	Chugai Pharmaceutical Co., Ltd.	NULL	complete	12		BOTH	34	Phase 3	Japan
7	JPRN-UMIN000025943	2014/08/07	07/02/2017	Long-term Safety of treatment with tocilizumab in the refractory patients with Takayasu Arteritis	Long-term Safety of treatment with tocilizumabin the refractory patients with Takayasu Arteritis - L ...	Takayasu arteritis	Intravenous administration of tocilizumab (8mg/kg/month) will be performed until December 31st, 2017.	Osaka Unversity	National Cerebral and Cardiovascular Center	Complete: follow-up continuing	16years-old	60years-old	Male and Female	9	Not selected	Japan
8	NCT02101333 (ClinicalTrials.gov)	June 10, 2014	17/2/2014	Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis	Efficacy and Tolerance of First-line Treatment With Tocilizumabin Active Takayasu Arteritis French P ...	TAKAYASU ARTERITIS	Drug: Tocilizumab	Assistance Publique - Hôpitaux de Paris	Chugai Pharmaceutical	Completed	18 Years	77 Years	All	18	Phase 3	France
9	JPRN-UMIN000008812	2012/10/01	01/10/2012	Efficacy and safety of tocilizumabmono-therapy in patients with large vessel vasculitis (LVV; giant ...		Rheumatoid arthritis	tocilizumab monotherapy	Department of Rheumatology & Clinical ImmunologySaitama Medical Center, Saitama Medical Universitity ...	NULL	Complete: follow-up complete	16years-old	80years-old	Male and Female	40	Not selected	Japan
10	JPRN-UMIN000007845	2012/05/01	01/05/2012	Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu Arteritis	Efficacy and Safety of treatment with tocilizumabin refractory patients with Takayasu Arteritis - AC ...	Takayasu arteritis	Intravenous administration of tocilizumab (8mg/kg/month) for 24 months	Department of Cardiovascular Medicine Graduate School of Medicine Osaka University	NULL	Complete: follow-up continuing	16years-old	60years-old	Male and Female	15	Not selected	Japan

First Previous1Next Last